(c)We Want to Hear from You



NCLEX-RN Exam Prep

Third Edition

Copyright © 2014 Pearson Education, Inc.

ISBN-10: 0-7897-5106-2

ISBN-13: 978-0-7897-5106-5

Warning and Disclaimer

Every effort has been made to make this book as complete and as accurate as possible, but no warranty or fitness is implied. The information provided is on an "as is" basis. The author and the publisher shall have neither liability nor responsibility to any person or entity with respect to any loss or damages arising from the information contained in this book or from the use of the CD or programs accompanying it.

When reviewing corrections, always check the print number of your book. Corrections are made to printed books with each subsequent printing.

First Printing: December 2013

Corrections for March 29, 2017

|Pg |Error – Third Printing |Correction |

|1 |Introduction, Second Bullet, First Sentence |Should read: |

| |Reads: | |

| |The RN is responsible for initiating peripheral IVs and giving IV Push |The RN is responsible for the initiating of peripheral IVs and giving IV Push medication. |

| |medication, but the PN is expected to be able to monitor IV lines and medication | |

| |and know how to recognize problems and the steps to take to correct them. | |

|1 |Introduction, Second Bullet, Last Sentence |Should read: |

| |Reads: | |

| |In many states, the licensed practical nurse can also initiate peripheral IV |In many states the licensed practical nurse can initiate peripheral IV lines. |

| |lines. | |

|4 |Introduction, Other Valuable Tools, Fourth Bullet |Should read: |

| |Reads: | |

| |Appendix D, “Most Commonly Prescribed Medications in the United States,” is a |Appendix D, “Commonly Prescribed Medications in the United States,” is a list of commonly prescribed |

| |list of commonly prescribed drugs with the generic and brand names and common |drugs with the generic and brand names and common nursing implications for use. |

| |nursing implications for use. | |

|6 |Introduction, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |The candidate can schedule the exam at a time that is convenient and usually |The candidate can schedule the exam at a time that is convenient and in most states can receive |

| |receives test results in seven days or sooner. |unofficial test results in a few days. |

|6 |Introduction, Advice for Preparing for the Exam, First Sentence |Should read: |

| |Reads: | |

| |Judicious use of this book, either alone or with a review seminar such as the one|Judicious use of this book, either alone or with a review seminar such as the one provided by |

| |provided by Rinehart and Associates, will help you achieve you goal of becoming |Rinehart and Associates with Pearson’s NCLEX-RN Review Complete Video Course, will help you achieve |

| |licenses to practice nursing. |you goal of becoming licenses to practice nursing. |

|7 |Introduction, Remove Second Bullet |Bullet to remove: |

| | |Dress in layers: The testing site might be cold or warn. |

|8 |Introduction, Contact the Author, Frist Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |If after reviewing with this text, you would like to contact us, you can do so at|If after reviewing with this text, you would like to contact us, you may do so at Pearson Education. |

| |Rinehart and Associates, PO Box 124, Booneville, MS 38829 or visit our website at| |

| |. | |

|9 |Study and Exam Preparation Tips, Eight Bullet |Should read: |

| |Reads: | |

| |Attend a live review like that offered by Rinehart and Associates. Participating |Attend a live review or use an online review such as Pearson’s NCLEX-RN Review Complete Video Course.|

| |in a live review where the instructors are dedicated to helping you succeed is | |

| |immeasurable in value. | |

|10 |Study and Exam Preparation Tips, Second Paragraph |Remove Second Paragraph |

|12 |Study and Exam Preparation Tips, Fifth Bullet, Third Sentence |Should read: |

| |Reads: | |

| |Write information that you remember about this topic on the paper or slate | |

| |provided in the testing area. | |

|12 |Study and Exam Preparation Tips, Sixth Bullet, Second Paragraph, First Sentence |Should read: |

| |Reads: | |

| |The nurse is attempting to evaluate the client’s knowledge of diabetes. |The nurse is attempting to evaluate the client’s knowledge of diabetes mellitus. |

|13 |Study and Exam Preparation Tips, Third Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |Applying heat vasodilates and causes increased bleeding. |Applying heat dilates blood vessels and causes increased bleeding. |

|15 |Chapter 1, First Paragraph, Fourth Sentence |Should read: |

| |Reads: | |

| |The recent test plan approved by the National Council Licensure Exam devotes |The recent test plan approved by the National Council Licensure Exam devotes 13%–19% to 12% - 18% of |

| |13%–19% of the Physiological Integrity section to pharmacology. |the Physiological Integrity section to pharmacology. |

|40 |Chapter 1, After Answer 16, Add |Add: |

| |Suggested Reading and Resources |Suggested Reading and Resources |

| | |Lippincott’s Illustrated Reviews: Pharmacology, 6th Edition, Whalen, Philadelphia, Lippincott |

| | |Williams and Wilkins, 2014. Lehne, R. Pharmacology for Nursing Care. 9th ed., St. Louis: Elsevier, |

| | |2016. |

|116 |Chapter 4, Management of the client with diabetes mellitus includes the |Should read: |

| |following:, Third Bullet, Second Sentence | |

| |Reads: |Medications used to treat diabetes mellitus include sulfonylurea agents, alpha-glucosidase |

| |Medications used to treat diabetes mellitus include sulfanylurea agents, |inhibitors, nonsulfonylurea agents, D-phenylalanine derivatives, meglitinides, biguanides, DPP-4 |

| |alpha-glucosidase inhibitors, nonsulfanylurea agents, D-phenylalanine |inhibitors, SGLT 2 inhibitors, bile acid sequestrants and thiazolidinediones. |

| |derivatives, and thiazolidinediones. | |

|134 |Chapter 5, Emphysema, First Paragraph, Starting with Second Sentence – delete and|Replace with: |

| |replace |Clients with early emphysematous changes may complain of dyspnea without cyanosis. As the disease |

| | |progresses the client may develop chronic hypoxia, cyanosis, pulmonary edema, and sometimes |

| | |respiratory failure. Polycythemia predisposes the client with emphysema to the development of clots. |

| | |(This should remove information on the older description of pink puffers and blue bloaters). |

|135 |Chapter 5, First Paragraph, Insert Sentence after Second Sentence |Sentence to Insert: |

| | |Lab Studies reveal increased RBCs and respiratory acidosis. |

|135 |Chapter 5, Seventh Sentence |Should read: |

| |Reads: | |

| |Attention is given to correcting acid/base imbalances, meeting nutritional needs,|Attention is given to correcting acid/base imbalances, meeting nutritional needs, providing frequent |

| |providing frequent oral care, and providing oxygen at low settings (2–3 liters |oral care, and providing oxygen at low settings (2–4 liters per minute). |

| |per minute). | |

|137 |Chapter 5, CAUTION, Remove First Two Paragraphs and Replace with new Paragraph |Replacement Paragraph: |

| | |Methylxanthines, such as theophylline and aminophylline are no longer considered the first class of |

| | |medications to treat COPD due to their serious side effects, interactions with other medications, and|

| | |narrow margin for safety. In most cases they have been replaced with short acting beta 2 agonists, |

| | |and long acting beta 2 agonists. Toxic symptoms associated with methylxanthines (theophylline and |

| | |aminophylline) include nausea, vomiting, tachycardia, palpitation, and hypotension. |

|137 |Chapter 5, CAUTION, Last Sentence |Should read: |

| |Reads: | |

| |Refer to Table 5.1 at the end of the chapter for full details on the pharmacology|Refer to Table 5.1 at the end of the chapter for details on the pharmacology agents administered for |

| |agents administered for respiratory conditions. |respiratory conditions. |

|137 |Chapter 5, Second Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |Management of the client with pleurisy includes the administration of analgesics,| |

| |such as Indocin (indomethicin) and other NSAIDS, antitussives with codeine, |Management of the client with pleurisy includes the administration of analgesics, such as Indocin |

| |antitussives, antibiotics, and oxygen therapy. |(indomethicin) and other NSAIDS, antitussives with codeine, antibiotics, and oxygen therapy. |

|139 |Chapter 5, First Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |These shortacting direct vasodilators include intravenous Flolan (epoprostenol), |These shortacting direct vasodilators include intravenous Flolan (epoprostenol), intravenous |

| |intravenous Remodulin (treprostinol), and oral Tracleer (bosentan). |Remodulin (treprostinil), and oral Tracleer (bosentan). |

|143 |Chapter 5, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |Hospital-acquired pneumonias include Pseudomonas pneumonia, staphylococcal |Hospital-acquired pneumonias include Pseudomonas pneumonia, staphylococcal pneumonia, Klebsiella |

| |pneumonia, Klebsiella pneumonia, Pneumocystis carinii pneumonia (PCP), and fungal|pneumonia, Pneumocystis jirovecki pneumonia (PCP), and fungal pneumonia. |

| |pneumonia. | |

|143 |Chapter 5, Second Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |Clients with cytomegalovirus, Pneumocystis carinii, or aspergillus will be |Clients with cytomegalovirus, Pneumocystis jirovecki, or aspergillus will be acutely ill. |

| |acutely ill. | |

|143 |Chapter 5, Last Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |The vaccine is recommended for people over age 65, those with cardiorespiratory |The vaccine is recommended for those people with cardiorespiratory conditions, those with chronic |

| |conditions, those with chronic illness, and those who are immunocompromised. |illness, and those who are immunocompromised. |

|145 |Chapter 5, Tuberculosis, First Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |The incidence of TB has been steadily increasing in the United States and | |

| |worldwide for the past 20 years. Although rates have been steadily dropping in |The incidence of TB has been steadily increasing worldwide for the past 20 years. Although rates in |

| |the United States due to TB control programs, TB remains a significant world |the United States have been dropping due to TB control programs, TB remains a significant world |

| |health problem. |health problem. |

|147 |Chapter 5, First Paragraph, Add Sentence at the End of Paragraph |Sentence to Add: |

| | |Clients with drug resistant TB are treated with additional medications for extended periods of time. |

|148 |Chapter 5, Bullet Points |Should read: |

| |Reads: | |

| |Hypoxia (decreased tissue oxygenation) |Hypoxia (persists with 100% oxygen administration) |

| | |Suprasternal and intercostal retractions |

| |Suprasternal and intercostal retractions |Presence of crackles (rales) or rhonchi |

| | |Diminished breath sounds |

| |Presence of crackles (rales) or rhonchi |Refractory hypoxemia (cardinal sign) Decreased lung compliance (cardinal sign) Diffuse bilateral |

| | |infiltrates on x-ray (cardinal sign) |

| |Diminished breath sounds | |

| | | |

| |Refractory hypoxemia (low levels of oxygen in the blood despite supplemental | |

| |oxygen delivered at high concentrations) | |

|149 |Chapter 5, First Bullet Point, First Sentence |Should read: |

| |Reads: | |

| |Maintaining endotrachial intubation and mechanical ventilation with positive end |Maintaining endotrachial intubation and mechanical ventilation with positive end expiratory pressure |

| |expiratory pressure (PEEP) or continuous positive airway pressure (CPAP). |(PEEP) or continuous positive airway pressure (CPAP) or ECMO. |

|150 |Chapter 5, Second Bullet, Insert New Sub-Bullet after Third Bullet |Sub-Bullet to Insert: |

| | | |

| | |Flow-cycled ventilators push air into the lungs until a predetermined or set flow rate is achieved |

| | |during inhalation. |

|150 |Chapter 5, Second Bullet, Replace Last Sub-Bullet |Replacement Sub-Bullet: |

| | |Complications sometimes associated with positive pressure ventilation include cardiac problems |

| | |(hypotension and fluid retention) and pulmonary problems (ventilator associated lung injury). |

| | |Gastrointestinal and nutrition problems and infection are also major complications that may occur |

| | |from positive pressure ventilation. |

|151 |Chapter 5, Add New Bullet at the end of Bullet List |New Bullet to Add: |

| | |Be familiar with the cause and intervention for high pressure and low pressure alarms |

|154 |Chapter 5, Second Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |Surgical management using umbrella-type filters is indicated for those who cannot|Surgical management using vena cava filter is indicated for those who cannot take anticoagulants as |

| |take anticoagulants as well as for clients who have recurrent emboli while taking|well as for clients who have recurrent emboli while taking anticoagulants. |

| |anticoagulants. | |

|163 |Chapter 5, Table 5.1, Row – Expectorants, Column – Name |Should read: |

| |Reads: | |

| |Ammonium |Ammonium |

| |Chloride |Chloride |

| |Guaifenesin K+ |Guaifenesin |

| |iodide |K+ iodide |

|164 |Chapter 5, Table 5.3, Column - Organism Responsible, Fourth Row |Should read: |

| |Reads: | |

| |Pneumocystis |Pneumocystis |

| |carinii |jirovecki |

|165 |Chapter 5, Table 5.4, Column – Name, Second Row |Should read: |

| |Reads: | |

| |Ethambutol HCI |Myambutol |

| |(myambutol) |(ethambutol HCl) |

| |(first-line drug) |(first-line drug) |

|165 |Chapter 5, Table 5.4, Column – Name, Fourth Row |Should read: |

| |Reads: | |

| |Fluoroquinolones |Floroquinolones |

| |(levoflaxacin, |(levofloxacin, |

| |Monofloxacin |Monofloxacin |

| |gatifloxacin) |gatifloxacin) |

|165 |Chapter 5, NOTE, Add Third Bullet |Bullet to Add: |

| | |Sirturo (combination of bedaquiline, pyrazinamide, and moxifloxacin): Used in the treatment of client|

| | |with multidrug resistant TB |

|168 |Chapter 5, Answers to the Exam Questions, Number 7, Second Sentence reads: |Should read: |

| |Cytoxan is an immunosuppressive drug; therefore, the client should notify the | |

| |doctor of symptoms associated with infection. |Cytoxan (cyclophosphamide) is an immunosuppressive drug; therefore, the client should notify the |

| | |doctor of symptoms associated with infection. |

|171 |Chapter 6, Second Sentence |Should read: |

| |Reads: | |

| |The nurse should be particularly sensitive to the client’s emotional needs |The nurse should be particularly sensitive to the client’s emotional needs because many genitourinary|

| |because many genitourinary disorders affect both the client’s physical and |disorders affect both the client’s physical and emotional well-being, as well as sexuality. |

| |emotional well-being, as well as her sexuality. | |

|173 |Chapter 6, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |Appropriate anti-infectives such as penicillin, Erythromycin, and Zithromax |Appropriate anti-infectives such as penicillin, Erythrocin (erythromycin), and Zithromax |

| |(azithromycin) are usually prescribed if the condition is due to an infection. |(azithromycin) are usually prescribed if the condition is due to an infection. |

|174 |Chapter 6, First Paragraph, First Sentence |Should read: |

| |Reads: | |

| |If a renal biopsy is performed, the client should be positioned on her abdomen. |If a renal biopsy is performed, the client should be positioned on his/her abdomen. |

|189 |Chapter 6, Second Bullet, Fourth Sentence |Should read: |

| |Reads: | |

| |Foods moderate in purine include bacon, pork, ham, chicken. |Foods moderate in purine include bacon, pork, ham, and chicken. |

|191 |Chapter 6, Third Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Discharge instructions include telling the client to increase fluid intake to |Discharge instructions include telling the client to increase fluid intake to 2,000–3,000 mL of water|

| |2,000–3,000 ml of water a day to decrease risk of bladder infections and to avoid|a day to decrease risk of bladder infections and to avoid alcohol, caffeinated beverages, and spicy |

| |alcohol, caffeinated beverages, and spicy foods. |foods. |

|200 |Chapter 6, Table 6.4, Second Column – Action, Fifth Row Down |Should read: |

| |Reads: | |

| |Anti-androgen Bbocks |Anti-androgen blocks |

| |DHT and shrinks the |DHT and shrinks the |

| |prostate. |prostate. |

|203 |Chapter 6, Number 9, Second Sentence |Should read: |

| |Reads: | |

| |The nurse should avoid clamping or kinking the nephrostomy because urine would be|The nurse should avoid clamping or kinking the nephrostomy tube because urine would be retained in |

| |retained in the kidney. |the kidney. |

|206 |Chapter 7, Herpes Simplex, Third Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |Infected newborn can develop fever, hypothermia, jaundice, seizures, poor |Infected newborns can develop fever, hypothermia, jaundice, seizures, poor feeding, and vesicular |

| |feeding, and vesicular skin eruptions. |skin eruptions. |

|212 |Chapter 7, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |According to the American Burn Association (2007), about 40,000 persons require |According to the American Burn Association (2012), about 40,000 persons require hospital care each |

| |hospital care each year for treatment of their injuries. |year for treatment of their injuries. |

|215 |Chapter 7, Nursing Care for Burn Victims, Bullet Points |Should read: |

| |Reads: | |

| |Emergent |Emergent (Resuscitative) |

| |Intermediate |Intermediate (Acute) |

| |Rehabilitative |Rehabilitative |

|217 |Chapter 7, Parkland Formula |Should read: |

| |Reads: | |

| |Ringer’s Lactate 4 mL * kg body weight * % TBSA |Ringer’s Lactate 4 mL x kg body weight x % TBSA |

|218 |Chapter 7, Number Three, at the top of the page, formula |Should read: |

| |Reads: | |

| |4 mL * 82 kg * 63 = 20,664 mL in 24 hours |4 mL x 82 kg x 63 = 20,664 mL in 24 hours |

|218 |Chapter 7, Consensus formula |Should read: |

| |Reads: | |

| |Ringer’s lactate or other balanced saline solution 2 ml–4 ml * kg body weight * %|Ringer’s lactate or other balanced saline solution 2 mL–4 mL x kg body weight x % TBSA |

| |TBSA | |

|218 |Chapter 7, Number Three, at the bottom of the page, formulas |Should read: |

| |Reads: | |

| |2 mL * 82 * 63 = 10,332 mL |2 mL x 82 x 63 = 10,332 mL |

| |4 mL * 82 * 63 = 20,664 mL |4 mL x 82 x 63 = 20,664 mL |

|263 |Chapter 9, Second Paragraph, Add sentence between Fourth and Fifth Sentences |Sentence to add: |

| | |IBS constipation pharmacological therapy include psylium hydropholic mucilloid (Metamucil), |

| | |lubiprostone (Amitiza), and linaclotide (Linzess). |

|263 |Chapter 9, Second Paragraph, Last Sentence |Should read: |

| |Reads: |Complementary and alternative therapies, such as hypnosis, acupuncture, probiotics, and peppermint |

| |Complementary therapies, such as hypnosis and acupuncture, are also used as forms|oil capsules are also used as forms of treatment. |

| |of treatment. | |

|265 |Chapter 9, First Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Intestinal obstruction and abscesses are complications requiring surgery, but are|Intestinal obstruction, abscesses, and fistulas may require surgery, but are more common with Crohn's|

| |more common with Crohn’s disease. |disease. |

|265 |Chapter 9, Diverticular Disease, Third Paragraph, Insert Sentence between First |Sentence to Insert: |

| |and Second Sentence |Abdominal ultrasonography may also be done and shows thickening or abscesses of the bowels. |

|267 |Chapter 9, Second Paragraph, Add Sentences at end of Paragraph |Sentence to add: |

| | |Uncomplicated appendicitis can be done via laparoscopy. Another minimally invasive procedure called |

| | |natural orifice transluminal endoscopic surgery (NOTES) can be used to remove organs such as the |

| | |appendix and gallbladder. These procedures can be done through the mouth, vagina, or rectum. There |

| | |are no visible incisions and fewer post operative complications with these procedures. |

|285 |Chapter 9, First Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Medications prescribed for clients with cirrhosis include antacids for gastric |Medications prescribed for clients with cirrhosis include antacids for gastric distress that could |

| |distress that could lead to bleeding, diuretics for fluid and ascites, and |lead to bleeding, diuretics for fluid and ascites, and cathartics (lactulose [Cephulac]), |

| |cathartics and enemas (lactulose [Cephulac]) to correct the pH in the bowel and |non-absorbable antibiotics, and enemas to correct the pH in the bowel and rid the body of ammonia. |

| |rid the body of ammonia. | |

|291 |Chapter 9, Second Sentence, Insert Sentence between Fourth and Fifth Sentences |Sentence to insert: |

| | |Fecal bacteriotherapy, using transported normal stool flora into an infected patient has had positive|

| | |results. |

|305 |Chapter 10, Second Set of Bullet Points, Add Bullet Point between Third and |Bullet Point to Add: |

| |Fourth Bullet |Daclizumab (Zenapex) |

|305 |Chapter 10, Third Paragraph, Add Second Sentence |Sentence to Add: |

| | |A spleenectomy may also be required. |

|313 |Chapter 10, First Set of Bullets, Add Bullet Point between Second and Third |Bullet Point to Add: |

| |Bullet |Apheresis |

|317 |Chapter 10, Table 10.3, Treatment Column, First Row, Add Sentence |Sentence to Add: |

| | |Keep IV access open, but do not infuse the blood in the iV tubing. |

|336 |Chapter 11, After Note, Third Bullet Point |Should read: |

| |Reads: |Avoid narcotic or medications that depress respiration however, opiods can be given to decrease |

| |Avoid narcotic or medications that depress respiration |agitation if it is due to pain |

|336 |Chapter 11, After Note, Add Fourth Bullet Point |Bullet Point to Add: |

| | |Sedatives, such as dexmedetomidine (Precedex), propovol (Diprivan) may be given for agitation and |

| | |ventilator asynchroncy |

|342 |Chapter 11, Cerebrovascular Accident/Stroke, First Sentence |Should read: |

| |Reads: | |

| |Strokes or “brain attacks” are the third leading cause of death and the leading |Strokes or “brain attacks” are the third leading cause of death and the major cause of disability in |

| |cause of disability in the United States. |the United States. |

|349 |Chapter 11, Simple Partial, First Sentence |Should read: |

| |Reads: | |

| |With a simple partial seizure, the client’s finger, arm, or hand might shake, |With a simple partial seizure, the client’s finger, arm, or hand might shake, autonomic symptoms (for|

| |autonomic symptoms (for example, flushing or heart rate changes), or special |example, flushing, discomfort in the epigastric region, and heart rate changes), or special sensory |

| |sensory symptoms might occur. |symptoms might occur. |

|351 |Chapter 11, First Paragraph, Last Bullet Point |Should read: |

| |Reads: | |

| |Stooped posture |Stooped or instable postures |

|351 |Chapter 11, Second Paragraph |Should read: |

| |Reads: | |

| |The management of Parkinson’s disease is usually accomplished by pharmaceutical |The management of Parkinson’s disease is usually accomplished by pharmaceutical interventions, |

| |interventions, including levodopa-carbidopa (Sinemet), benztropine mesylate |including levodopa-carbidopa (Sinemet), benztropine mesylate (Cogentin), amantidine hydrochloride |

| |(Cogentin), amantidine hydrochloride (Symmetrel), ropinirole hydrochloride |(Symmetrel), ropinirole hydrochloride (Requip), pramipexole (Mirapex), rotigotine {(Neupro) available|

| |(Requip), pramipexole (Mirapex), MAO inhibitors (for example, selegiline |as a trandermal patch}, MAO inhibitors (for example, selegiline [Eldepryl]), CONT inhibitors (for |

| |[Eldepryl]), CONT inhibitors (for example, entacapone [Comtess]), antidepressants|example, entacapone [Comtess]), antidepressants (for example, Elavil or Prozac), and antihistamines |

| |(for example, Elavil or Prozac), and antihistamines (for example, Benadryl) for |(for example, Benadryl) for mild anti-cholinergic effects. |

| |mild anti-cholinergic effects. | |

|352 |Chapter 11, Add Bullet Point between First and Second Bullet Points of the Second|Bullet Point to Add: |

| |Set of Bullet Points |Myalgia |

|354 |Chapter 11, Multiple Sclerosis, First Bullet Point |Should read: |

| |Reads: | |

| |Weakness |Weakness, fatigue, and spasticity |

|352 |Chapter 11, Multiple Sclerosis, Third Bullet Point |Should read: |

| |Reads: | |

| |Pain |Pain and numbness |

|352 |Chapter 11, Multiple Sclerosis, Fourth Bullet Point |Should read: |

| |Reads: | |

| |Visual changes (blurring of vision, double vision, scotoma, fatigue, spasticity, |Visual changes (blurring of vision, diplopia, and scotoma) |

| |numbness, cognitive changes) | |

|352 |Chapter 11, Multiple Sclerosis, Add Fifth Bullet Point |Bullet Point to Add: |

| | |Cognitive changes |

|355 |Chapter 11, Fourth Bullet Point |Should read: |

| |Reads: | |

| |Mitoxantrone (Novantrone). |Mitoxantrone (Novantrone), natalizumab (Tysabri) |

|355 |Chapter 11, Add Bullet Between Fourth and Fifth Bullet Point |Bullet Point to Add: |

| | |Oral agents, such as fingolimod (Gilenya) and tiflunomide (Anbagio) |

|357 |Chapter 11, NOTE |Should read: |

| |Reads: | |

| |Complications for plasmapheresis procedure include: infection of the vascular |Complications for plasmapheresis procedure include: infection and/or clotting of the vascular device,|

| |device, fluid volume deficit, and decreased potassium and calcium levels. |fluid volume deficit, and decreased potassium and calcium levels. |

|358 |Chapter 11, Table 11.7, Row: Pathophysiology of area affected, Column: |Sentence to Add: |

| |Huntington’s Disease, Add Second Sentence |Decrease in gamma aminobutyric acid (GABA) |

|358 |Chapter 11, Table 11.7, Row: |Treatment to Add: |

| |Pharmacalogic Treatment, Column: Huntington’s Disease, Add Treatment |Tetrabenazine (Xenazine) |

|372 |Chapter 11, NOTE |Should read: |

| |Reads: | |

| |Other drugs for multiple sclerosis include mitoxantrone (Novantrone), an anti |Other drugs for multiple sclerosis include mitoxantrone (Novantrone), an anti tumor antibiotic that |

| |tumor antibiotic that is also given in prostate cancer and glatiramer acetate |is also given in prostate cancer, glatiramer acetate (Copaxone), natalizumab (Tysabri), fingolimod |

| |(Copaxone). |(Gilenya), and tiflunomide (Anbagio) |

|400 |Chapter 13, Risk Factors for Specific Cancers, Third Bullet |Should read: |

| |Reads: | |

| |Cervical: Risk factors include early sexual activity, early childbearing, |Cervical: Risk factors include early sexual activity, age below 17 at first time pregnancy, multiple |

| |multiple partners, human papillomavirus (HPV) or human immunodeficiency virus |partners, obesity, use of birth control pills, diet low in fruits and vegetables, human |

| |(HIV) infection, smoking, use of DES by the mother during pregnancy, and chronic |papillomavirus (HPV) or human immunodeficiency virus (HIV) infection, smoking, use of DES by the |

| |cervical infections. |mother during pregnancy, and chronic cervical infections. |

|401 |Chapter 13, First Bullet |Should read: |

| |Reads: | |

| |Colon: Risk factors include family history, polyps, chronic inflammatory bowel |Colon: Risk factors include family history, polyps, obesity, type 2 diabetes, chronic inflammatory |

| |disease, alcohol use, smoking, and a diet high in fat and protein and low in |bowel disease, alcohol use, smoking, and a diet high in fat and protein and low in fiber. |

| |fiber. | |

|401 |Chapter 13, Second Bullet |Should read: |

| |Reads: | |

| |Esophagus: Risk factors include use of tobacco, use of alcohol, and chronic |Esophagus: Risk factors include use of tobacco, use of alcohol, obesity, HPV infection, and chronic |

| |irritation. |irritation. |

|401 |Chapter 13, Third Bullet |Should read: |

| |Reads: | |

| |Larynx: Risk factors include use of tobacco, nutritional deficiencies |Larynx: Risk factors include use of tobacco, nutritional deficiencies (riboflavin), chronic |

| |(riboflavin), chronic laryngitis, use of alcohol, and exposure to carcinogens. |laryngitis, use of alcohol, HPV infection, and exposure to carcinogens. |

|401 |Chapter 13, Fifth Bullet |Should read: |

| |Reads: | |

| |Hodgkin’s lymphoma: Risk factors include exposure to chemical agents, and viral |Hodgkin’s lymphoma: Risk factors include exposure to chemical agents, a weakened immune system, |

| |infections. |living in a developed country, and viral infections. |

|401 |Chapter 13, Sixth Bullet |Should read: |

| |Reads: | |

| |Liver: Risk factors include cirrhosis, hepatitis B, exposure to certain toxins, |Liver: Risk factors include cirrhosis, hepatitis B, exposure to certain toxins, smoking, type 2 |

| |smoking, and alcohol use. |diabetes, obesity, and alcohol use. |

|401 |Chapter 13, Ninth Bullet |Should read: |

| |Reads: | |

| |Ovarian: Risk factors include a diet high in fat; alcohol use; a history of |Ovarian: Risk factors include a diet high in fat; women with first pregnancy after age 35, obesity, |

| |cancer of the breast, endometrium, or colon or a family history of ovarian or |and a history of cancer of the breast, endometrium, or colon or a family history of ovarian or breast|

| |breast cancer; anovulation; nulliparity; and infertility. |cancer. |

|401 |Chapter 13, Tenth Bullet |Should read: |

| |Reads: | |

| |Non-Hodgkin’s lymphoma: Risk factors include viral infections; exposure to |Non-Hodgkin’s lymphoma: Risk factors include viral infections; exposure to chemicals and/or ionizing |

| |chemicals and/or ionizing radiation; autoimmune disorders. |radiation; weakened immune system; autoimmune disorders. |

|401 |Chapter 13, Eleventh Bullet |Should read: |

| |Reads: | |

| |Pancreas: Risk factors include a diet high in fat, smoking, exposure to |Pancreas: Risk factors include a diet high in fat, cirrhosis of the liver, smoking, exposure to |

| |industrial chemicals, diabetes mellitus, and chronic pancreatitis. |industrial chemicals, diabetes mellitus, and chronic pancreatitis. |

|401 |Chapter 13, Thirteenth Bullet |Should read: |

| |Reads: | |

| |Skin: Risk factors include exposure to sun, exposure to various chemicals |Skin: Risk factors include exposure to sun, or UV light exposure to various chemicals (arsenic and |

| |(arsenic and coal tar), scarring or chronic irritation of the skin, and ancestry |coal tar), scarring or chronic irritation of the skin, skin moles, weakened immunity, and ancestry |

| |(highest incidence in those of Celtic ancestry with red or blond hair, fair skin,|(highest incidence in those of Celtic ancestry with red or blond hair, fair skin, and blue eyes). |

| |and blue eyes). | |

|401 |Chapter 13, Cancer Prevention, Third Bullet |Should read: |

| |Reads: |Women age 40 to 44 should have the choice to start annual breast cancer screening with mammograms; |

| |A baseline mammogram should be done at age 40 and yearly after age 40. |45-54 should have mammograms yearly; 55 and older should switch to mammograms every 2 years or |

| | |continue yearly screening. |

|403 |Chapter 13, Major Types of Cancer, Third Sentence |Should read: |

| |Reads: | |

| |The American Cancer Society lists the four most prevalent new cancers as colon, |The American Cancer Society lists the four most prevalent cancers as colon, lung, breast, and |

| |lung, breast, and prostate. |prostate. |

|404 |Chapter 13, First Paragraph, Last Sentence |Should read: |

| |Reads: | |

| |Blood tests include the CBC, which will reveal anemia, and the CEA, which might |Blood tests include the CBC, which will reveal anemia, and the carcinogenic embryonic acid (CEA), |

| |be elevated. |which might be elevated. |

|404 |Chapter 13, Third Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Typical treatment involves chemotherapy with 5-fluorouracil (FU), oxaliplatin |Typical treatment involves chemotherapy with 5-fluorouracil (FU), oxaliplatin (Eloxatin), |

| |(Eloxatin), leucovorin (Wellcovorin), and/or levamisole (Ergamisol). |capecitabine (Xeloda), and leucovorin (Wellcovorin). |

|409 |Chapter 13, Prostate Cancer, First Two Bullets |Should read: |

| |Reads: | |

| |Hematuria |Hematuria |

| |Pain during ejaculation |Nocturia |

| | |Pain during ejaculation |

|410 |Chapter 13, First Paragraph, Add Sentence at beginning of Paragraph |Sentence to Add: |

| | |Robotic assisted laparoscopic radical prostatectomy may be done for cancer that is localized and the |

| | |client's PSA is less than 10 ng/ML. |

|410 |Chapter 13, First Paragraph, Last Sentence |Should read: |

| |Reads: | |

| |Important nursing interventions after prostate surgery include the following |Important nursing interventions after radical prostate surgery include the following (Additional |

| |(Additional discussion available in Chapter 6, “Care of the Client with |discussion available in Chapter 6, “Care of the Client with Genitourinary Disorders.”): |

| |Genitourinary Disorders.”): | |

|411 |Chapter 13, Second Bullet |Should read: |

| |Reads: | |

| |Administration of estrogen or gonadotropin-releasing hormones, such asleuprolide |Administration of luteinizing hormone releasing hormone agonists and anti androgen drugs, such as |

| |(Lupron), magestrol (Megace), medroxyprogesterone (Depo-Provera), abarelix |leuprolide (Lupron), magestrol (Megace), flutamide (Eulexin), goserelin (Zoladex), and bicalutamide |

| |(Plenaxis), flutamide (Eulexin), goserelin (Zoladex), bicalutamide (Casodex), and|(Casodex). |

| |diethystilbestrol (DES) | |

|413 |Chapter 13, First Paragraph, Move Sixth Sentence and place between Sentences Four|Sentence to move: |

| |and Five |This procedure helps to prevent negative aspects of node excision, such as decreased mobility of the |

| | |limb, numbness, and lymphedema. |

|413 |Chapter 13, Delete Second Sixth Bullets |Bullets to Delete: |

| | |Methotrexate (Trexall) |

| | |Vinorelbine (Navelbine) |

|417 |Chapter 13, Table 13.4, Cancer Type: Pancreatic cancer, Diagnostics |Should read: |

| |Reads: | |

| |Laboratory: Elevated CEA, amylase, lipase, and bilirubin (depending on |Laboratory: Elevated CEA, amylase, lipase, and bilirubin (depending on involvement); |

| |involvement); |Tumor markers: CA 19-9, CA 242, HCG beta. X-ray: CT scan, MRI, ERCP most definitive diagnostic tool).|

| |Tumor markers: CA 19-9, CA 242, CA 72-4, HCG beta. X-ray: CT scan, MRI, ERCP most| |

| |definitive diagnostic tool). | |

|417 |Chapter 13, Table 13.4, Cancer Type: Pancreatic cancer, Treatment |Should read: |

| |Reads: | |

| |Pharmacological intervention: 5-FU, cisplatin, mitomycin. |Pharmacological intervention: 5-FU, gemcitabine and doctaxel. |

| |Surgery: Whipple procedure. |Surgery: Whipple procedure. |

| |Endoscopy: Biliary to relieve obstruction can be inserted. |Endoscopy: Biliary to relieve obstruction can be inserted. |

| |Radiation: Usually external beam radiation. Radioactive iodine seeds might be |Radiation: Usually external beam radiation. Radioactive iodine seeds might be implanted. |

| |implanted. Intraoperative radiation therapy might be used. |Intraoperative radiation therapy might be used. |

|418 |Chapter 13, Table 13.4, Cancer Type: Ovarian cancer, Diagnostics |Should read: |

| |Reads: | |

| |Laboratory: CA 125 (a ovarian nostic tool because benign problems can also cause |Laboratory: CA 125 (a ovarian nostic tool because benign problems can also cause elevation. Genetic |

| |elevation. |BCRA 1 and BCRA 2. |

| |X-ray: Ultrasound, CT scan, IVP, UGI. |X-ray: Ultrasound, CT scan, IVP, UGI. |

|418 |Chapter 13, Cancer Type: Cervical cancer (most are squamous cell carcinomas), |Should read: |

| |Treatment | |

| |Reads: |Pharmacological intervention: Usually has a poor response; paclitaxel, carboplatin, Mitomycin. |

| |Pharmacological intervention: Usually has a poor response; paclitaxel, |Surgery: Depending on extent—conization, hysterectomy, pelvic exenteration. |

| |carboplatin, hydroxyurea. |Treatments: LEEP (loop electrosurgical excision procedure); laser therapy; cryotherapy; conization |

| |Surgery: Depending on extent—conization, hysterectomy, pelvic exenteration. |Radiation: External followed by intracavity. |

| |Treatments: LEEP (loop electrosurgical excision procedure); laser therapy; | |

| |cryotherapy. | |

| |Radiation: External followed by intracavity. | |

|419 |Chapter 13, Cancer Type: Leukemia (unregulated WBC proliferation in bone marrow),|Should read: |

| |Clinical Manifestations | |

| |Reads: |Frequent infections/colds, decreased platelet functions evidenced by nosebleeds, hematuria, bruising,|

| |Frequent infections/colds, decreased platelet functions evidenced by nosebleeds, |and so on, weight loss, fatigue, anorexia, headache, hematuria, ecchymoses, bone pain or swelling. |

| |hematuria, bruising, and so on, weight loss, fatigue, anorexia, headache, bone | |

| |pain or swelling. | |

|419 |Chapter 13, Cancer Type: Leukemia (unregulated WBC proliferation in bone marrow),|Should read: |

| |Treatment, Other medications | |

| |Reads: |Other medications include antibiotics, antibacterials, antifungals, and antivirals. |

| |Other medications: antibiotics and antibacterials (for example, amnioglycosides | |

| |[Gentamicin, Tobramycin, vancomycin], antifungals [amphotericin B, Nizoral], and | |

| |antivirals [ganciclovir]). | |

|419 |Chapter 13, Cancer Type: Leukemia (unregulated WBC proliferation in bone marrow),|Should read: |

| |Treatment | |

| |Reads: |Pharmacological intervention: Chemotherapy is the standard treatment— bortezomig (Velcade) and |

| |Pharmacological intervention: Chemotherapy is the standard treatment— melphalan, |thalidomide (Thalomid) combined with dexamethazone. Biphosphanates are also prescribed. Bone marrow |

| |vincristine, cyclophosphamide combined with Decadron, doxorubicin, thalidomide |transplantation prescribed for the bone disease. |

| |(Thalomid). Clients with no improvement after treatment might be treated with | |

| |bortezomib Velcade). Biphosphanates are also prescribed. Bone marrow | |

| |transplantation. | |

|420 |Chapter 13, Cancer Type: Non-Hodgkin’s lymphoma (lymphoid tumors without presence|Should read: |

| |of Reed- Sternberg cells), Treatment | |

| |Reads: |Pharmacological intervention: multi- or single chemotherapy (Fludarabine) use, Rituximab (Rituxan) |

| |Pharmacological intervention: multi- or single chemotherapy (Fludarabine) use, |and alentuzumab (Campath). |

| |Rituximab (Rituxan). |Radiation: Radiation therapy may be used. Stem cell transplantation. |

| |Radiation: Radiation therapy may be used. | |

|422 |Chapter 13, Table 13.5, Side Effects of Radiation: Dry Skin, Column: Nursing Care|Should read: |

| |of Clients Receiving External Radiation | |

| |Reads: |Avoid harsh soaps, alcohol skin preparations, and hot baths. |

| |Avoid soaps, alcohol skin preparations, and hot baths. Use moisturizers. | |

|423 |Chapter 13, Second Paragraph, Add Sentence between Third and Fourth Sentence |Sentence to Add: |

| | |No pregnant women are children younger than 16 should be allowed to visit. |

|424 |Chapter 13, Second Bullet |Should read: |

| |Reads: | |

| |Recommended dressing is either a gauze dressing taped on all four sides or a |Change the dressing every 48-72 hours or per the facility protocol. |

| |transparent dressing. | |

|425 |Chapter 13, Nursing Implementations, Delete First Bullet |Bullet to delete: |

| | |Blood should not be drawn from the TPN port, but it can be drawn from the venous port. |

|427 |Chapter 13, Bone Marrow and Peripheral Stem Cell Transplantation, First |Should read: |

| |Paragraph, Last Sentence | |

| |Reads: |Sources of stem cells include bone marrow, peripheral stem cell apheresis, and umbilical cord |

| |Sources of stem cells include bone marrow, peripheral circulating blood, and | |

| |umbilical cord. | |

|448 |Chapter 14, Fractures, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |Four major categories of bone fractures are classified according to the amount of|Categories of bone fractures include: |

| |tissue damage: | |

|449 |Chapter 14, First Paragraph, First Sentence |Should read: |

| |Reads: |Other types of fractures include pathological fractures, stress fractures, or compression fractures. |

| |A fifth type of fracture is the pathological fracture. |These fractures occur without major trauma or injury. |

|451 |Chapter 14, General Treatment for Fractures, Add Last Bullet |Last Bullet to Add: |

| | |Assess neurovascular status |

|452 |Chapter 14, Bullet Reads: |Sentence to Add: |

| |Balanced suspension traction: Uses more than one force of pull to establish |Should read: |

| |alignment (see Figure 14.8). |Balanced suspension traction: Uses more than one force of pull to establish alignment. Provides |

| | |counter traction for better activity. Movement or a change in position will not alter counter |

| | |traction (see Figure 14.8). |

|453 |Chapter 14, First Bullet |Should read: |

| |Reads: |Weights must hang free and be the number of pounds ordered. |

| |Weights must hang free. | |

|453 |Chapter 14, Third Bullet |Should read: |

| |Reads: |Ropes should remain within the pulley without fraying or looseness. |

| |Ropes should remain within the pulley. | |

|453 |Chapter 14 Seventh Bullet |Should read: |

| |Reads: |Countertraction is usually provided by the clients’ weight in running traction.  Movement of the |

| |Countertraction is usually provided by the clients’ weight. |client's body or bed position alters the counter traction. |

|456 |Chapter 14, First Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |One course of treatment includes medications, which can include the use of |One course of treatment includes medications, which can include the use of long-term (12 weeks) |

| |long-term (4– 6 weeks) antibiotic therapy. |antibiotic therapy. |

|456 |Chapter 14, First Paragraph, Sixth Sentence |Should read: |

| |Reads: | |

| |The following contains nursing interventions you need to know for the exam: |The following contains nursing interventions and irrigation after debridement you need to know for |

| | |the exam: |

|456 |Chapter 14, First Bullet Points, Insert Bullet between the Fifth and Sixth Bullet|Bullet to Insert: |

| |Points |Antibiotic saturated bone cement beads as a wound packing |

|456 |Chapter 14, Delayed Union or Healing, Second Paragraph, Second Sentence |Should read: |

| |Reads: |The management of this condition includes surgical internal fixation, use of bone grafts, exogen |

| |The management of this condition includes surgical internal fixation, use of bone|therapy, and electrical bone stimulation.  Exogen therapy uses low intensified ultrasound to the |

| |grafts, and electrical bone stimulation. |bone.  Used daily for 20 minutes.  There are no contraindications or adverse effects to this |

| | |therapy.  |

|457 |Chapter 14, Osteoporosis, Fifth Bullet |Should read: |

| |Reads: | |

| |Low dietary calcium intake |Low dietary calcium intake and vitamin D |

|457 |Chapter 14, Osteoporosis, Seventh Bullet |Should read: |

| |Reads: | |

| |Alcohol consumption |Excessive alcohol intake |

|457 |Chapter 14, Last Paragraph, Last Sentence |Should read: |

| |Reads: | |

| |In addition, the client should be taught to avoid alcohol and caffeine. |In addition, the client should be taught to avoid excessive alcohol and caffeine. |

|458 |Chapter 14, Delete NOTE at the top of page | |

|458 |Chapter 14, First Set of Bullet Points, First Bullet |Should read: |

| |Reads: | |

| |Biphosphonates (examples are Fosamax, Boniva, and Didronel) |Biphosphonates (examples are Fosamax, Boniva, Alendronate, Risedronate, Ibandronate, and Zoledronic |

| | |Acid) |

|458 |Chapter 14, First Set of Bullet Points, Sixth Bullet |Should read: |

| |Reads: | |

| |Selective estrogen receptor modules or SERMs (for example, Evista) |Selective estrogen receptor modules or SERMs (for example, Raloxifene) |

|458 |Chapter 14, First Set of Bullet Points, Add Seventh Bullet |Bullet Point to Add: |

| | |Monoclonal antibody (for example Denosumab)  |

|459 |Chapter 14, Diagnosis of Osteoarthritis, Second Sentence |Should read: |

| |Reads: | |

| |These tests might reveal a slight elevation in the erythrocyte sedimentation rate|These tests might reveal a slight elevation in the erythrocyte sedimentation rate (ESR) and |

| |(ESR) if inflammation is present in the synovial fluid. |high-sensitivity C-reactive protein (hsCRP) if inflammation is present in the synovial fluid. |

|459 |Chapter 14, Treatment of the Client with Osteoarthritis, Fourth Sentence |Should read: |

| |Reads: | |

| |Some drugs used in treatment are acetaminophen (Tylenol), meloxicam (Mobic), |Some drugs used in treatment are acetaminophen (Tylenol), Lidoderm patch, buspirone HCL (Buspar |

| |cortisone into the joint by the HCP, muscle relaxers (Skelaxin), glucosamine, and|cream) meloxicam (Mobic), cortisone into the joint by the HCP, muscle relaxers (Skelaxin), |

| |arthritic rubs (such as Aspercreme and capsaicin cream [Zostrix]). |glucosamine, and arthritic rubs (such as Aspercreme and capsaicin cream [Zostrix]). |

|460 |Chapter 14, Fibromyalgia, Bullet Point ‘Medications’, Third Bullet |Should read: |

| |Reads: | |

| |Skeletal muscle relaxants (cyclobenzaprine [Flexeril]) |Skeletal muscle relaxants (cyclobenzaprine [Flexeril] and Trazodone (Desyrel) |

|460 |Chapter 14, Fibromyalgia, Bullet Point ‘Medications’, Fifth Bullet |Should read: |

| |Reads: | |

| |Short-term sleep aids (for example, Zolpidem [Ambien]) |Short-term sleep aids (for example, Zolpidem [Ambien] and Tramadol (Ultram) |

|461 |Chapter 14, Add Bullets between First and Second Bullet after ‘Arthralgia or achy|Bullets to Add: |

| |joints’ |Back pain  |

| | |Visual Disturbances |

|461 |Chapter 14, Gout, Add Sentence at the End of the First Paragraph |Sentence to Add: |

| | |Clients should avoid the use of aspirin and diuretics which can also precipitate an attack. |

|462 |Chapter 14, First Paragraph, Fourth Sentence |Should read: |

| |Reads: | |

| |Probenecid (Benemid) might be given to help with the excretion of uric acid. |Probenecid (Benemid) or Colbenemid might be given to help with the excretion of uric acid. |

|462 |Chapter 14, First Paragraph, Add Sixth Sentence |Sentence to Add: |

| | |Pegloticase (Krystexxa) can be given IV in severe cases.  |

|463 |Chapter 14, Add New Bullet to the First Set of Bullet Points at the end |Bullet to Add: |

| | |Joint deformities |

|463 |Chapter 14, Add New Bullet to the Second Set of Bullet Points at the end |Bullet to Add: |

| | |(HLA-B 27) |

|463 |Chapter 14, Third Set of Sub-Bullets, First Bullet |Should read: |

| |Reads: | |

| |Antiarthritics (for example, etanercept [Enbrel], infliximab [Remicade], and |Antiarthritics (for example, etanercept [Enbrel], infliximab [Remicade], adalimumab [Humira], and |

| |adalimumab [Humira]) |anarinra [Kineret], and tofacitinib [Xeljanz]) |

|464 |Chapter 14, First Bullet under NOTE |Should read: |

| |Reads: | |

| |Application of heat and ice to the affected joints. This can be done at home or |Application of heat and ice to the affected joints. Heated paraffin wax works well to provide heat to|

| |by a physical therapy department. |arthritic hands. This can be done at home or by a physical therapy department. |

|464 |Chapter 14, Last Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |The disease, which is characterized by remissions and exacerbations, is more |The disease, which is characterized by remissions and exacerbations, is more common in women between |

| |common in women between the ages of 15 and 40. |the ages of 20 and 40. |

|465 |Chapter 14, Second Paragraph, Insert Sentence Between the Second and Third |Sentence to Insert: |

| |Sentences |Laboratory tests are similar to the ones used to diagnose Rheumatoid arthritis.  |

|465 |Chapter 14, Third Bullet |Should read: |

| |Reads: | |

| |Cardiovascular: Pericarditis and myocardial ischemia. |Cardiovascular: Pericarditis, myocardial ischemia, and Raynauds phenomenum.  |

|466 |Chapter 14, Second Paragraph, Insert Sentence Between the Fourth and Fifth |Sentence to Insert: |

| |Sentences |Belimumag (Benlysta) is a monoclonal antibiody specifically indicated for SLE. |

|466 |Chapter 14, Musculoskeletal Surgical Procedures, Add Two Sentences at the end of |Sentences to Add: |

| |Paragraph |Minimally invasive surgical procedures are available for Hip and Total Knee replacements.  These |

| | |procedures result in faster recovery, mobility and less client pain.  |

|469 |Chapter 14, Interventions Post-Amputation Surgery, Second Sentence |Should read: |

| |Reads: | |

| |Specific problems that might occur with the client after an amputation include |Specific problems that might occur with the client after an amputation include pain, contractures, |

| |pain, contractures, hemorrhage, and infection. |Neuromas, hemorrhage, and infection. |

|529 |Chapter 16, Last Paragraph, Second Sentence |Should read: |

| |Reads: | |

| |However, if the infection is caused by Group A beta hemolytic streptococcus, |However, if the infection is caused by Group A beta hemolytic streptococcus, antibiotic therapy is |

| |antibiotic therapy is ordered. |ordered. |

|534 |Chapter 16, Paragraph after NOTE, Last Sentence |Should read: |

| |Reads: | |

| |Respiratory therapy with ribavirin (Virazole) is ordered for those with |Respiratory therapy with ribavirin (Virazole) is ordered for those with bronchiolitis caused by |

| |bronhiolitis caused by respiratory synctial virus. |respiratory synctial virus. |

|565 |Chapter 16, Surviving Childhood Cancer, First Sentence |Should read: |

| |Reads: | |

| |Each year approximately 12,400 children ranging in age from birth to 19 years are|Each year approximately 15,000 children ranging in age from birth to 19 years are diagnosed with some|

| |diagnosed with some form of cancer. |form of cancer (). |

|589 |Chapter 17, Heading for Anxiety-related Disorders |Should read: |

| |Reads: | |

| |Anxiety-related Disorders | |

| | |Anxiety Disorders |

|589 |Chapter 17, First Paragraph and Bullet Points under Anxiety |Should read: |

| |Reads: | |

| |Anxiety-related disorders are sometimes referred to as neurotic disorders and |Anxiety disorders include the following categories: |

| |include the following categories: | |

| | |Separation anxiety disorder |

| |Generalized anxiety disorder |Agorophobia |

| |Post-traumatic stress disorder |Generalized anxiety disorder |

| |Dissociative identity disorder |Obsessive-Compulsive disorder |

| |Somatoform disorder |Social anxiety |

| |Panic disorder |Specific phobia |

| |Phobic disorder |Body dysmorphic disorder |

| |Obsessive-compulsive disorder |Panic disorder |

|589 |Chapter 17, Add Sentence to Last Paragraph |Sentence to Add: |

| | | |

| | |Other disorders characterized by stress and anxiety include somatic disorder, trauma related |

| | |disorder, and dissociative disorder. This section will review the most commonly occurring anxiety |

| | |disorders. |

|590 |Chapter 17, Second Heading |Should read: |

| |Reads: | |

| |Post-traumatic Stress Disorder |Trauma Related Disorder (Posttraumatic Stress Disorder) |

|590 |Chapter 17, Last Paragraph, Add Sentence |Sentence to Add: |

| | |Interventions for PTSD include the use of antidepressants, antihypertensives, and cognitive |

| | |restructuring. |

|591 |Chapter 17, First Heading |Should read: |

| |Reads: | |

| |Dissociative Identity Disorder |Dissociative Disorder (Dissociative Identity Disorder) |

|591 |Chapter 17, Second Heading, Paragraph and Bullet Points |Should read: |

| |Reads: | |

| |Somatoform Disorder |Somatic Disorder |

| |Somatoform disorder is characterized by the appearance of physical symptoms for |Somatic disorder is characterized by the appearance of physical symptoms for which there is no |

| |which there is no apparent organic or physiological cause. The client with a |apparent organic or physiological cause. The client with a somatic disorder continuously seeks |

| |somatoform disorder continuously seeks medical treatment for a physical complaint|medical treatment for a physical complaint even though he has been told there is no evidence of |

| |even though he has been told there is no evidence of physical illness. Somatoform|physical illness. Somatic disorders include the following: |

| |disorders include the following: | |

| | |Functional neurological disorder (conversion disorder) |

| |Conversion disorder |Illness anxiety disorder (hypochondriasis) |

| |Hypochondriasis |Factitious disorder |

| |Pain disorder |Somatic symptom disorder |

| |Somatization disorder | |

|592 |Chapter 17, First Heading, Paragraph and Bullet Points |Should read: |

| |Reads: | |

| |Phobic Disorders |Specific Phobia |

| |Phobic disorders are expressed as intense, irrational fears of some object, |Phobic disorders are expressed as intense, irrational fears of some object, situation, or activity. A|

| |situation, or activity. A person with a phobic disorder experiences anxiety when |person with a phobic disorder experiences anxiety when he comes in contact with the situation or |

| |he comes in contact with the situation or feared object. Although the client |feared object. Although the client recognizes that the fear is irrational, the phobia persists. |

| |recognizes that the fear is irrational, the phobia persists. Major phobic |According to the DSM V some common phobias include: |

| |disorders include: | |

| | |Agoraphobia (fear of open spaces) |

| |Agoraphobia |Acrophobia (fear of heights) |

| |Social phobia |Claustrophobia (fear of enclosed spaces) |

| |Specific phobia |Mysophobia (fear of germs) |

|593 |Chapter 17, Remove and Replace Section ‘Personality Disorders” |Replacement Paragraphs: |

| | |The second major category of reality-based disorders focuses on the client with faulty personality |

| | |development. |

| | | |

| | |Unlike clients with an anxiety disorder, who believe that everything is wrong with them, clients with|

| | |personality disorders seldom seek treatment. They see nothing wrong with their behavior and therefore|

| | |see no need to change. |

| | | |

| | |Personality disorders refer to pervasive maladaptive patterns of behavior that are evident in the |

| | |perceptions, communication, and thinking of an individual. The DSM V lists ten personality disorders.|

| | |These disorders are: paranoid, schizoid, schizotypal, histrionic, narcissistic, antisocial, |

| | |borderline, avoidant, dependent, and obsessive compulsive. |

|593 |Chapter 17, Insert NOTE Box Before ‘Cluster A’ |NOTE BOX to Insert: |

| | |The previous edition of the DSM (DSM IV TR) grouped personality disorders into clusters based on |

| | |collective behaviors. Cluster A: Odd Eccentric included paranoid, schizoid, and schizotypal. Cluster |

| | |B: Dramatic Erratic included histrionic, narcissistic, antisocial, and borderline. Cluster C Anxious |

| | |Fearful included avoidant, dependent, and obsessive compulsive. |

|593 |Chapter 17, Remove Cluster A Section and Replace |Replacement Paragraph: |

| | |Although they represent different personalities, individuals with paranoid, schizoid, and |

| | |schizotypal personalities all display behavior that is odd or eccentric. |

|594 |Chapter 17, Schizoid Personality Disorder, Add Sentence at end of Paragraph |Sentence to Add: |

| | |Antidepressants and antipsychotics may be used to improve flattened affect. |

|594 |Chapter 17, Schizotypal Personality Disorder, Add Sentences at end of Paragraph |Sentences to Add: |

| | |The DSM V identifies schizotypal personality disorder as both a personality disorder and as the first|

| | |of the schizophrenia spectrum disorders. Low dose antipsychotics and antidepressant medication helps |

| | |with day to day functioning. |

|594 |Chapter 17, Remove Cluster B Section and Replace |Replacement Paragraph: |

| | |Persons with histrionic, narcissistic, antisocial, or borderline personality disorder tend to display|

| | |behavior that is overly dramatic, attention-seeking, and manipulative with little regard for others.|

|594 |Chapter 17, Histrionic Personality Disorder, Add Sentences at end of Paragraph |Sentence to Add: |

| | |Medication therapy includes the use of antidepressants and anxiolytics. |

|594 |Chapter 17, Narcissistic Personality Disorder, Add Sentences at end of Paragraph |Sentence to Add: |

| | |Interventions include cognitive behavioral therapy, family therapy, and group therapy. |

|595 |Chapter 17, Remove Cluster C Section and Replace |Replacement Paragraph: |

| | |Persons with avoidant, dependent, and obsessive –compulsive exhibit behaviors that are anxious and |

| | |fearful. |

|595 |Chapter 17, Avoidant Personality Disorder, Add Sentences at end of Paragraph |Sentence to Add: |

| | |Interventions include the use of antidepressants, individual, and group therapy. |

|595 |Chapter 17, Dependent Personality Disorder, Add Sentences at end of Paragraph |Sentence to Add: |

| | |Interventions include cognitive and behavioral therapy. |

|596 |Chapter 17, Obsessive-Compulsive Personality Disorder, Add Sentences at end of |Sentence to Add: |

| |Paragraph |Interventions include antidepressant medication, group therapy, and self-help groups. |

|597 |Chapter 17, Schizophrenia, First Paragraph, Third Sentence |Should read: |

| |Reads: | |

| |Theories offered regarding the cause of schizophrenia include genetics, |Theories offered regarding the cause of schizophrenia include genetics, environmental factors, and |

| |environmental factors, and biological alterations in the neurotransmitters |biological alterations in the neurotransmitters serotonin, glutamate, and dopamine. |

| |serotonin and dopamine. | |

|597 |Chapter 17, Schizophrenia, Third Paragraph, First Sentence |Should read: |

| |Reads: | |

| |The DSM 5 no longer classifies schizophrenia into subtypes (catatonic, |The DSM V no longer classifies schizophrenia into subtypes (catatonic, disorganized, paranoid, |

| |disorganized, paranoid, residual, and undifferentiated) based on the cient’s |residual, and undifferentiated) based on the cient’s history and presenting symptoms. |

| |history and presenting symptoms. | |

|597 |Chapter 17, Schizophrenia, Paragraph Three, Add Last Sentence and Bullet Points |Sentence and Bullet Points to Add: |

| | |The DSM V identifies four main symptom groups of schizophrenia and their characteristics. These are: |

| | | |

| | |Positive symptoms characterized by hallucinations, delusions, bizarre behavior, paranoia, abnormal |

| | |movement, gross errors in thinking |

| | |Negative symptoms characterized by absence of interest in hygiene, lack of motivation, inability to |

| | |experience pleasure |

| | |Cognitive symptoms characterized by changes in memory, thinking, and attention; impaired executive |

| | |functioning |

| | |Affective symptoms characterized by no expression and no emotion |

|598 |Chapter 17, Remove First NOTE Box |NOTE Box to remove: |

| | |You might want to refer to your nursing textbook for a more complete description of the subtypes and |

| | |positive and negative symptoms associated with schizophrenia. |

|598 |Chapter 17, Last Paragraph, Last Sentence |Should read: |

| |Reads: | |

| |Atypical antipsychotics, such as Risperdal (risperidone), can be given in smaller|Atypical antipsychotics, such as Risperdal (risperidone) and Latuda (lurasidone), can be given in |

| |doses, produce fewer side effects, and help manage the negative symptoms of |smaller doses, produce fewer side effects, and help manage the negative symptoms of schizophrenia |

| |schizophrenia more effectively than the older antipsychotics such as Thorazine |more effectively than the older antipsychotics such as Thorazine (chloropromazine). |

| |(chloropromazine). | |

|598 |Chapter 17, NOTE Box at Bottom of Page, Second Sentence |Should read: |

| |Reads: | |

| |Refer to the chapter on psychopharmacology in your psychiatric nursing textbook |Refer to the chapter on psychopharmacology in your psychiatric nursing textbook for more information |

| |for more information on the typical and atypical antipsychotics. |on antipsychotic medication and the treatment of adverse effects including EPSE. |

|599 |Chapter 17, Paragraph under CAUTION Box, Second Sentence |Should read: |

| |Reads: | |

| |The prognosis for the client with schizophrenia is based on the subtype, the |The prognosis for the client with schizophrenia is based on the severity of symptoms, compliance with|

| |severity of symptoms, and compliance with treatment. |treatment, and community and family support for the client. |

|600 |Chapter 17, Acute Mania, Add Sentence at the End of Second Paragraph |Sentence to Add: |

| | |As mania intensifies the client may develop psychosis and auditory hallucinations. |

|600 |Chapter 17, Caution Box, Add Sentence at the End of First Paragraph |Sentence to Add: |

| | |Blood should be drawn in the morning 8 – 12 hours after the last dose of medication. |

|600 |Chapter 17, Caution Box, Add Sentence at the End of Second Paragraph |Sentence to Add: |

| | |Other interventions include gastric lavage, intravenous urea, mannitol, or aminophylline to hasten |

| | |lithium excretion. In some instances hemodialysis may be necessary. |

|606 |Chapter 17, Psychological Disorders of Childhood and Adolescence, First |Replacement Sentence |

| |Paragraph, Remove Second Sentence and Bullet Points |In this section we will review disruptive, control, and conduct disorders (conduct disorder and |

| | |oppositional defiant disorder), neurodevelopmental disorders (ADHD and autism spectrum disorder), and|

| | |eating feeding disorders (anorexia nervosa and bulimia). |

|607 |Chapter 17, Change Heading |Should read: |

| |Reads: | |

| |Autistic Spectrum Disorder |Autism Spectrum Disorder |

|607 |Chapter 17, Autistic Spectrum Disorder, First Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Autistic Spectrum Disorder now encompasses the previous DSM-IV autistic disorder |Autism Spectrum Disorder now encompasses the previous DSM-IV autism disorder, Asperger’s disorder, |

| |(autism), Asperger’s disorder, childhood disintegrative disorder, and pervasive |childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified. |

| |developmental disorder not otherwise specified. | |

|607 |Chapter 17, Autistic Spectrum Disorder, Third Paragraph, First Sentence |Should read: |

| |Reads: | |

| |Autistic children are not able to relate to people or respond to social or |Autism children are not able to relate to people or respond to social or emotional cues in a normal |

| |emotional cues in a normal manner. |manner. |

|613 |Chapter 17, Table 17.6, Drug Column, Last Row |Should read: |

| |Reads: | |

| |Olanzapine (Zyprexa, |Olanzapine (Zyprexa, |

| |Zyprexa, Zydis) |Zydis) |

|615 |Chapter 17, Table 17.6, Drug Column, Sixth Row |Should read: |

| |Reads: | |

| |Antidepressants (MAOI) |Antidepressants (MAOI) |

This errata sheet is intended to provide updated technical information. Spelling and grammar misprints are updated during the reprint process, but are not listed on this errata sheet.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download